Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Herpes simplex virus latency.

Robin Lachmann¹

¹Department of Medicine, Box 157, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 2QQ, UK. rhl20@cam.ac.uk

Expert Reviews in Molecular Medicine

|February 28, 2004

Summary

This summary is machine-generated.

Herpes simplex virus (HSV-1 and HSV-2) establishes lifelong latent infections. Molecular studies of HSV latency offer insights into treating recurrent HSV disease.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Adults With Acid Sphingomyelinase Deficiency Have Sustained Improvements in Clinical Outcomes With up to 5 Years of Olipudase Alfa Enzyme Replacement Therapy: ASCEND Trial Final Results.

Journal of inherited metabolic disease·2026

Same author

Advances in Therapeutics-Enzyme Replacement Therapy: Long-Term Evaluation and New Approaches.

Journal of inherited metabolic disease·2026

Same author

Enzyme replacement therapy compared with best supportive care for the treatment of Pompe Disease: a systematic review and network meta-analysis.

Health technology assessment (Winchester, England)·2026

Same author

Cardiovascular Morbidity and Mortality in Fabry Disease.

Circulation. Genomic and precision medicine·2026

Same author

Correspondence on "Phenylalanine hydroxylase deficiency diagnosis and management: A 2023 evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)" by Smith et al.

Genetics in medicine : official journal of the American College of Medical Genetics·2026

Same author

The cost-effectiveness of enzyme replacement therapies versus best supportive care for treating late onset Pompe disease in the UK NHS.

The European journal of health economics : HEPAC : health economics in prevention and care·2025

Same journal

Advances in m6A Modification in Pregnancy-Related Disorders and Female Reproductive Endocrine Diseases.

Expert reviews in molecular medicine·2026

Same journal

Dysregulation of the urea cycle - potential targets for treatment and diagnosis in prostate cancer.

Expert reviews in molecular medicine·2026

Same journal

RAGE-Mediated Signaling in Gynecological Disorders: Review of Molecular Mechanisms and Therapeutic Perspectives.

Expert reviews in molecular medicine·2026

Same journal

Two Decades of Therapeutic Trials in Supratentorial Intracerebral Hemorrhage: Lessons from Failure and Success.

Expert reviews in molecular medicine·2026

Same journal

Developing Galectin-3-Targeted Therapeutics in Diseases: Three Distinct Galectin-3 Segments for Targeting.

Expert reviews in molecular medicine·2026

Same journal

Current <i>in vitro</i> myocardial infarction co-culture models and their verification for clinical relevance.

Expert reviews in molecular medicine·2026

See all related articles

Area of Science:

Virology
Molecular Biology
Immunology

Background:

Herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) are common human viruses.
These viruses cause lifelong latent infections.
Reactivation of latent HSV is the primary cause of disease.

Purpose of the Study:

To review molecular mechanisms of HSV latency.
To discuss implications for treating recurrent HSV disease.

Main Methods:

Review of molecular studies on HSV latency in model systems.

Main Results:

Understanding HSV latency mechanisms is crucial.
Insights gained inform potential therapeutic strategies.

Conclusions:

Further research into HSV latency can lead to better treatments for recurrent HSV infections.